-
With more than 25 years experience as a critical care nurse, Barbara Jordan, RN, MSN, CCRN, could read the bleak signs and symptoms of the patient before her like a map to a destination she had been before.
-
How do you know if your needlestick prevention program is working? A decrease in injuries is a good barometer but sometimes that could reflect a lack of reporting rather than an improvement in safety.
-
Accurate microbiologic diagnosis of prosthetic joint infection (PJI) is problematic. Infecting organisms reside in a biofilm, and standard culture techniques appear to have suboptimal sensitivity.
-
In a move that may clear the way for federal legislation aimed at preventing outbreaks of bloodborne diseases in ambulatory care, a broad-based coalition of patient safety advocates and health care groups has launched a national education campaign on needle safety.
-
The Joint Commission and other national infection prevention groups made a point to include catheter-related urinary tract infections (CA-UTIs) traditionally considered a relatively benign adverse event in a recently issued compendium targeting the major health care-associated infections (HAIs).
-
The recently reported rapid deaths of two patients infected with a new highly toxic staph strain suggests the deadly pathogen is emerging in the community and certainly will pose a threat to hospitals, a researcher tells Hospital Infection Control & Prevention.
-
In this issue: FDA warning on topical anesthetics; antipsychotics increase sudden cardiac death; the step up vs step down debate; treating pain, fatigue, mood, and sleep in fibromyalgia; FDA Actions.
-
CDC investigators analyzed 15 years of surveillance data of culture-confirmed cases of tuberculosis from the 50 states and the District of Columbia, identifying 201,399 with isoniazid- and rifampin-susceptibility results.
-
Schistosomiasis is the most important trematode infection worldwide, transmitted to humans through skin contact with infested freshwater.
-
SPF stands for "sun protection factor," but if FDA recommendations change, the name will soon stand for "sunburn protection factor" because of the recognition that current SPF testing reflects erythema effects of UVA light in the 320-340 nm and UVB light in the 290-320 nm wavelengths, but does not necessarily reflect efficacy for other photodamaging wavelengths.